No Data
Gilead Sciences Trades in the Green for Seventh Straight Session
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Evaluating Regeneron Pharmaceuticals Against Peers In Biotechnology Industry
Ready for Fed Rate Cuts? Biotech's Potential to Watch
BeiGene Stock Rises on FDA Fast Track Tag for Investigational Cancer Therapy
Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.